von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C-Reference-Cited by-同舟云学术

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

Published:2018-11 Issue:9 Volume:6 Page:1401-1409
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Takaya Hiroaki¹,Kawaratani Hideto¹,Tsuji Yuki¹,Nakanishi Keisuke¹,Saikawa Soichiro¹,Sato Shinya¹,Sawada Yasuhiko¹,Kaji Kosuke¹,Okura Yasushi¹,Shimozato Naotaka¹,Kitade Mitsuteru¹,Akahane Takemi¹,Moriya Kei¹,Namisaki Tadashi¹,Mitoro Akira¹^ORCID,Matsumoto Masanori²,Fukui Hiroshi¹,Yoshiji Hitoshi¹

Affiliation:

1. Third Department of Internal MedicineNara Medical UniversityKashiharaJapan

2. Department of Blood Transfusion MedicineNara Medical UniversityKashiharaJapan

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640618779660

Reference35 articles.

1. Cancer and liver cirrhosis: implications on prognosis and management

2. Liver cirrhosis

3. Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

4. World Health Organization International Agency for Research on Cancer.GLOBOCAN 2012: Estimated cancer incidence mortality and prevalence worldwide in 2012.http://globocan.iarc.fr/Default.aspx(2012).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring potential therapeutic strategy for hepatocellular carcinoma and COVID-19 using bioinformatics analysis;Egyptian Journal of Medical Human Genetics;2024-08-05

2. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis;Hepatology Research;2024-06-05

3. Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives;Cancers;2024-03-31

4. Novel biomarker genes for the prediction of post-hepatectomy survival of patients with NAFLD-related hepatocellular carcinoma;Cancer Cell International;2023-11-10

5. Von Willebrand Factor as a Biomarker for Liver Disease – An Update;Journal of Clinical and Experimental Hepatology;2023-11